No company is going to market with a drug with this history of Peginesatide... it would be suicide.
Takeda just paid out 6 Billion in fines for Actos, so it was a case of once bitten twice shy that there was no possibility that they were going to retest the waters with Osmotis after its withdrawal. Due to the Impossibility of defending a "known Killer" returning to market, any new party would be insane to tread the lawyer infested waters of the United States with such easy prey.
Eat the losses ( Yes it Sucks ), and move on to open waters ... slow prey gets eaten.
Why was Takeda slammed with 6 billion?
Would you care to take a stab at listing other killers that are still on the market.
Well then try listing all the ESAs that have not been suspected in patient deaths.
I'm sure you know better than the exec at FMS.
Do you know the condition of the patients in this market.
You do know the population this is approved for don't you.